| European Case Law Identifier: | ECLI:EP:BA:2008:T110706.20081203 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 03 December 2008 | ||||||||
| Case number: | T 1107/06 | ||||||||
| Application number: | 99203920.6 | ||||||||
| IPC class: | A61K 38/16 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | B | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Botulinum toxins for modulating cholinergic controlled secretions | ||||||||
| Applicant name: | ALLERGAN, INC. | ||||||||
| Opponent name: | Société de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S.) | ||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Main Request: added subject-matter (no); inventive step (no) First Auxiliary Request: added subject-matter (no): subject-matter of disclaimer originally disclosed; inventive step (yes) |
||||||||
| Catchwords: |
A disclaimer does not infringe Article 123(2) EPC if its subject-matter was disclosed as an embodiment of the invention in the application as filed (see points 29-49). |
||||||||
| Cited decisions: | |||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t061107eu1.html
Date retrieved: 17 May 2021
34 references found.
Click X to load a reference inside the current page, click on the title to open in a new page.EPC Articles
Offical Journal of the EPO
XOJ EPO 2017, A50 - Interlocutory decision of the Technical Board of Appeal 3.3.09 dated 17 October 2016 - T 437/14